Includes film-coated (disintegration < 30 min) and other coated types (disintegration < 60 min).
Understanding Ph. Eur. Monograph 0478: The Standard for Tablets
: To provide bulk and cohesive properties. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-
General Monograph 0478, titled "Tablets," is a foundational quality standard within the European Pharmacopoeia (Ph. Eur.). The European Pharmacopoeia is the primary source of official quality standards for medicines and their ingredients in Europe, providing a legal and scientific basis for quality control throughout a product's lifecycle.
user wants a long article about the European Pharmacopoeia monograph "Tablets" with number 0478. I need to conduct a comprehensive search to gather information on this specific monograph, its role in pharmaceutical quality control, and related contexts. The search plan includes several steps, such as verifying the 0478 number, gathering technical details, finding the official text, understanding European Pharmacopoeia functions, and covering related topics like harmonization and regulatory use. I will start with the first set of searches. search results have provided several relevant sources. The first result is a page from drugfuture.com that appears to contain the full text of the monograph. The second result from gmp-compliance.org discusses revisions to the monograph. The third result from faq.edqm.eu provides context on disintegration tests. The fourth result from ages.at discusses a study on tablet divisibility. The fifth result from journal.pda.org discusses weight uniformity. The sixth result from nhathuocngocanh.com provides a definition and characters of tablets. The seventh result from rrrry.com is a Chinese news article about the revision. The eighth result from ouci.dntb.gov.ua provides a reference. The search on edqm.eu yielded FAQ pages. The search on pheur.edqm.eu yielded no results. The search on general monograph Tablets yielded several results including a PharmTech article, EDQM training modules, and updates. The search on content uniformity and dissolution testing yielded relevant results. The search on general monograph Tablets dosage form yielded some relevant pages. The search on ICH Q4B yielded results about harmonization. Now I need to open the key pages to gather detailed information.'ve gathered a significant amount of information from the opened pages. The drugfuture.com page provides the full text of the monograph. The gmp-compliance.org page details revisions. The faq.edqm.eu page discusses disintegration tests. The ages.at page discusses a study on tablet divisibility. The nhathuocngocanh.com page provides a definition. The pharmtech.com pages discuss tablet splitting and dosage uniformity. The EDQM training module page provides context. The gmp-navigator.com page provides details on revisions. The ICH Q4B page discusses harmonization. I also have the British Pharmacopoeia pages. Now I need to gather more information on the European Pharmacopoeia's role, the EDQM, and the legal status. I'll also search for updates or revisions beyond 2018. search results have provided additional information on the legal status, EDQM, and revisions. I have a good amount of material to work with. The user's question has high authority requirements, I should prioritize using official sources like the EDQM and official pharmacopoeia texts. The article should be comprehensive, covering the definition, categories, production requirements, subdivision rules, quality tests, legal status, harmonization, recent updates, and practical implications. I will structure the article with an introduction, the definition and types of tablets, production requirements, subdivision of tablets, quality control tests, legal and regulatory framework, harmonization with other pharmacopoeias, recent revisions and updates, and a conclusion. I will cite the sources appropriately. Now I will start writing the article. tablet is the most common and widely recognized dosage form in modern medicine, yet the quality standards governing its manufacture are exceptionally rigorous and legally binding. At the heart of these standards for Europe and beyond lies the . This document is far more than a simple definition; it is the comprehensive regulatory blueprint that dictates how tablets are designed, produced, and tested to ensure patient safety. Includes film-coated (disintegration Understanding Ph
Required to disintegrate within 5 minutes in cold water. 3. Dissolution
: Since January 2018, revised standards mandate a suitable dissolution test for immediate-release forms unless otherwise justified. General Monograph 0478, titled "Tablets," is a foundational
Understanding this monograph is essential for pharmaceutical manufacturers, quality control chemists, and regulatory professionals to ensure every tablet produced is safe, effective, and consistent. Scope and Definition
To guarantee batch-to-batch reproducibility and therapeutic safety, Monograph 0478 enforces rigorous standards during the production phase: 1. Mechanical Strength
The serves as the definitive, legally binding regulatory standard for oral solid dosage forms manufactured, distributed, and marketed across Europe. Maintained by the European Directorate for the Quality of Medicines & HealthCare (EDQM) , this general dosage form monograph establishes the precise core definition, critical physical testing frameworks, manufacturing directives, and specialized subset criteria necessary to ensure uniform pharmaceutical quality and consumer safety. Core Definition and Material Composition